Association of the Apolipoprotein A-I gene polymorphisms with cardiovascular disease risk factors and atherogenic indices in patients from assam, Northeast India

1Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics – 2015 update: A report from the American Heart Association. Circulation. 2015; 131(4): e29-e322. 10.1161/CIR.0000000000000152.MozaffarianDBenjaminEJGoASArnettDKBlahaMJCushmanM Heart disease and stroke statistics – 2015 update: A report from the American Heart Association Circulation. 2015 131 4 e29 e322 10.1161/CIR.0000000000000152Open DOISearch in Google Scholar

2Remaley AT, Rifai N, Warnick GR. Lipids, lipoproteins, apolipoproteins and cardiovascular risk factors. In: Burtis CA, Ashwood ER, Bruns DE, Eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 5th ed., 1st Indian reprint. New Delhi, India: Elsevier (Reed Elsevier India Pvt. Ltd.). 2012: 731-805.RemaleyATRifaiNWarnickGR. Lipids, lipoproteins, apolipoproteins and cardiovascular risk factors BurtisCAAshwoodERBrunsDE Tietz Textbook of Clinical Chemistry and Molecular Diagnostics 5th 1st Indian reprint New Delhi India Elsevier (Reed Elsevier India Pvt. Ltd.) 2012 731805Search in Google Scholar

3Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18): 1837-1847.WilsonPWD’AgostinoRBLevyDBelangerAMSilbershatzHKannelWB. Prediction of coronary heart disease using risk factor categories Circulation. 1998 97 18 1837 1847Search in Google Scholar

4Dallinga-Thie GM, Bu XD, Trip MLS, Rotter JI, Lusis AJ, de Bruin TWA. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III. J Lipid Res. 1996; 37(1): 136-147.Dallinga-ThieGMBuXDTripMLSRotterJILusisAJde BruinTWA. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III J Lipid Res. 1996 37 1 136 147Search in Google Scholar

5Wojciechowski AP, Farrall M, Cullen P, Wilson TME, Bayliss JD, Farren B, et al. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23q-q24. Nature. 1991; 349(6305): 161-164.WojciechowskiAPFarrallMCullenPWilsonTMEBaylissJDFarrenB Familial combined hyperlipidaemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23q-q24 Nature. 1991 349 6305 161 164Search in Google Scholar

6de Franca E, Alves JG, Hutz MH. APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. Braz J Med Biol Res. 2005; 38(4): 535-541.de FrancaEAlvesJGHutzMH. APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children Braz J Med Biol Res. 2005 38 4 535 541Search in Google Scholar

7Ding Y, Zhu MA, Wang ZX, Zhu J, Feng JB, Li DS. Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome. J Biomed Biotechnol. 2012; 2012: 509420. 10.1155/2012/509420.DingYZhuMAWangZXZhuJFengJBLiDS. Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome J Biomed Biotechnol. 2012 2012 509420 10.1155/2012/509420Open DOISearch in Google Scholar

8Swanson CR, Li K, Unger TL, Gallagher MD, van Deerlin VM, Agarwal P, et al. Lower plasma apolipoprotein A1 levels are found in Parkinson’s disease and associate with apolipoprotein A1 genotype. Mov Disord. 2015; 30(6): 805-812.SwansonCRLiKUngerTLGallagherMDvan DeerlinVMAgarwalP Lower plasma apolipoprotein A1 levels are found in Parkinson’s disease and associate with apolipoprotein A1 genotype Mov Disord. 2015 30 6 805 812Search in Google Scholar

9Smach MA, Edziri H, Charfeddine B, Ben Othman L, Lammouchi T, Ltaief A, et al. Polymorphism in apoA1 influences high-density lipoprotein cholesterol levels but is not a major risk factor of Alzheimer’s disease. Dement Geriatr Cogn Disord Extra. 2011; 1(1): 249-257.SmachMAEdziriHCharfeddineBBen OthmanLLammouchiTLtaiefA Polymorphism in apoA1 influences high-density lipoprotein cholesterol levels but is not a major risk factor of Alzheimer’s disease Dement Geriatr Cogn Disord Extra. 2011 1 1 249 257Search in Google Scholar

10Liu ZH, Xiao YM, Tang LY, Jiang L, Wang YJ, Zhang RC, et al. Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer risk. Lipids Health Dis. 2015; 14: 143. 10.1186/s12944-015-0132-0.LiuZHXiaoYMTangLYJiangLWangYJZhangRC Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer risk Lipids Health Dis. 2015 14 143 10.1186/s12944-015-0132-0Open DOISearch in Google Scholar

11Hsu MC, Lee KT, Hsiao WC, Wu CH, Sun HY, Lin IL, et al. The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: A 10-year follow-up study. BMC Cancer. 2013; 13: 330. 10.1186/1471-2407-13-330.HsuMCLeeKTHsiaoWCWuCHSunHYLinIL The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: A 10-year follow-up study BMC Cancer. 2013 13 330 10.1186/1471-2407-13-330Open DOISearch in Google Scholar

12Miroshnikova VV, Rodygina TI, Demina EP, Kurjanov PS, Urazgildeeva SA, Gurevich VS, et al. Association of apoprotein A-1 genetic variants with development of atherosclerosis in the population of St. Petersburg. Russian J Genet Appl Res. 2011; 1: 411-415. 10.1134/S207905971105011X.MiroshnikovaVVRodyginaTIDeminaEPKurjanovPSUrazgildeevaSAGurevichVS Association of apoprotein A-1 genetic variants with development of atherosclerosis in the population of St. Petersburg Russian J Genet Appl Res. 2011 1 411 415 10.1134/S207905971105011XOpen DOISearch in Google Scholar

13Coban N, Onat A, Guclu-Geyik F, Komurcu-Bayrak E, Can G, Erginel-Unaltuna N. Gender-specific associations of the APOA1 -75G>A polymorphism with several metabolic syndrome components in Turkish adults. Clin Chim Acta. 2014; 431: 244-249. 10.1016/j.cca.2014.01.017.CobanNOnatA Guclu-GeyikF Komurcu-BayrakECanG Erginel-UnaltunaN. Gender-specific associations of the APOA1 -75G>A polymorphism with several metabolic syndrome components in Turkish adults Clin Chim Acta. 2014 431 244 249 10.1016/j.cca.2014.01.017Open DOISearch in Google Scholar

14Souverein OW, Jukema JW, Boekholdt SM, Zwinderman AH, Tanck MWT. Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD. Eur J Hum Genet. 2005; 13(4): 445-451.SouvereinOWJukemaJWBoekholdtSMZwindermanAHTanckMWT. Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD Eur J Hum Genet. 2005 13 4 445 451Search in Google Scholar

15Wang XL, Badenhop R, Humphrey K, Wilcken DE. New MspI polymorphism at +83 bp of the human apolipoprotein A1 gene: Association with increased circulating high density lipoprotein cholesterol levels. Genet Epidemiol. 1996; 13(1): 1-10.WangXLBadenhopRHumphreyKWilckenDE. New MspI polymorphism at +83 bp of the human apolipoprotein A1 gene: Association with increased circulating high density lipoprotein cholesterol levels Genet Epidemiol. 1996 13 1 1 10Search in Google Scholar

16Dawar R, Gurtoo A, Singh R. Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: A pilot study in a North Indian population. Am J Clin Pathol. 2010; 134(2): 249-255.DawarRGurtooASinghR. Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: A pilot study in a North Indian population Am J Clin Pathol. 2010 134 2 249 255Search in Google Scholar

17Liao BH, Cheng KQ, Dong SH, Liu HD, Xu ZL. Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease. Diagn Pathol. 2015; 10: 102. 10.1186/s13000-015-0328-7LiaoBHChengKQDongSHLiuHDXuZL. Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease Diagn Pathol. 2015 10 102 10.1186/s13000-015-0328-7Open DOISearch in Google Scholar

18Kim YR, Hong SH. The apolipoprotein A1 polymorphisms were associated with decreased risk for metabolic syndrome in Koreans. Genes Genome. 2015; 37(10): 875-882. 10.1007/s13258-015-0318-x.KimYRHongSH. The apolipoprotein A1 polymorphisms were associated with decreased risk for metabolic syndrome in Koreans Genes Genome. 2015 37 10 875 882 10.1007/s13258-015-0318-xOpen DOISearch in Google Scholar

19Pagani F, Sidoli A, Giudichi GA, Barenghi L, Vergani C, Baralle FE. Human apolipoprotein A-I gene promoter polymorphism: Association with hyperalphalipoproteinemia. J Lipid Res. 1990; 31(8): 1371-1377.PaganiFSidoliAGiudichiGABarenghiLVerganiCBaralleFE. Human apolipoprotein A-I gene promoter polymorphism: Association with hyperalphalipoproteinemia J Lipid Res. 1990 31 8 1371 1377Search in Google Scholar

20Wang XL, Badenhop R, Humphrey K, Wilcken DEL. C to T and G to A transitions are responsible for loss of a MspI restriction site in the 59-region of the human apolipoprotein AI gene. Hum Genet. 1995; 95(4): 473-475.WangXLBadenhopRHumphreyKWilckenDEL. C to T and G to A transitions are responsible for loss of a MspI restriction site in the 59-region of the human apolipoprotein AI gene Hum Genet. 1995 95 4 473 475Search in Google Scholar

21Bora K, Pathak MS, Borah P, Hussian MI, Das D. Single nucleotide polymorphisms of APOA1 gene and their relationship with serum apolipoprotein A-I concentrations in the native population of Assam. Meta Gene. 2016; 7: 20-27. 10.1016/j.mgene.2015.10.005.BoraKPathakMSBorahPHussianMIDasD. Single nucleotide polymorphisms of APOA1 gene and their relationship with serum apolipoprotein A-I concentrations in the native population of Assam Meta Gene. 2016 7 20 27 10.1016/j.mgene.2015.10.005Open DOISearch in Google Scholar

22Bora K, Pathak MS, Borah P, Das D. Variation in lipid profile across different patterns of obesity – Observations from Guwahati, Assam. J Clin Diagn Res. 2015; 9(11): OC17-OC21.BoraKPathakMSBorahPDasD. Variation in lipid profile across different patterns of obesity – Observations from Guwahati Assam J Clin Diagn Res. 2015 9 11 OC17OC21Search in Google Scholar

23Kotokey R, Hazarika S, De A. Lipid abnormalities in hypertensive urban population of Dibrugarh district of upper Assam. Indian Heart J. 2006; 58(6): 405-408.KotokeyRHazarikaSDeA. Lipid abnormalities in hypertensive urban population of Dibrugarh district of upper Assam Indian Heart J. 2006 58 6 405 408Search in Google Scholar

24Gururaj G, Girish N, Isaac MK. Mental, neurological and substance abuse disorders: Strategies towards a systems approach. In: National Commission on Macroeconomics and Health (NCMH) Background Papers – Burden of disease in India. New Delhi, India: NCMH, Ministry of Health & Family Welfare, Government of India. 2005: 226-250.GururajGGirishNIsaacMK. Mental, neurological and substance abuse disorders: Strategies towards a systems approach National Commission on Macroeconomics and Health (NCMH) Background Papers – Burden of disease in India New Delhi India NCMH, Ministry of Health & Family Welfare Government of India 2005 226250Search in Google Scholar

25National Cardiovascular Disease Database. Ministry of Health & Family Welfare, Government of India and World Health Organisation. http://www.searo.who.int/india/topics/cardiovascular_diseases/NCD_Resources_National_CVD_database-Final_Report.pdf. (Last accessed on June 21 2016.)National Cardiovascular Disease Database Ministry of Health & Family Welfare Government of India and World Health Organisation http://www.searo.who.int/india/topics/cardiovascular_diseases/NCD_Resources_National_CVD_database-Final_Report.pdf (Last accessed on June 21 2016.)Search in Google Scholar

26Shah SK, Saikia M, Snehlata C, Ramachandran A. High prevalence of type 2 diabetes in urban population of north eastern India. Int J Diabetes Dev Countries. 1999; 19: 144-147.ShahSKSaikiaMSnehlataCRamachandranA. High prevalence of type 2 diabetes in urban population of north eastern India Int J Diabetes Dev Countries. 1999 19 144 147Search in Google Scholar

27Ridkar PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-1 and B-100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005; 294(3): 326-333.RidkarPMRifaiNCookNRBradwinGBuringJE. Non-HDL cholesterol, apolipoproteins A-1 and B-100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women JAMA. 2005 294 3 326 333Search in Google Scholar

28Pereira T. Dyslipidemia and cardiovascular risk: lipid ratios as risk factors for cardiovascular disease. In: Kelishandi R, Ed. Dyslipidemia – From Prevention to Treatment. Rijeka, Croatia: InTech Europe. 2012: 279-302.PereiraT. Dyslipidemia and cardiovascular risk: lipid ratios as risk factors for cardiovascular disease KelishandiR Dyslipidemia – From Prevention to Treatment. Rijeka Croatia InTech Europe 2012 279302Search in Google Scholar

29Kennel WB. Risk stratification of dyslipidemia: Insights from the Framingham Study. Curr Med Chem Cardiovasc Hematol Agents. 2005; 3(3): 187-193.KennelWB. Risk stratification of dyslipidemia: Insights from the Framingham Study Curr Med Chem Cardiovasc Hematol Agents. 2005 3 3 187 193Search in Google Scholar

30National Cholesterol Education Program. Third and Final report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation. 2002; 106(25): 3143-3421.National Cholesterol Education Program. Third and Final report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Circulation 2002 106 25 3143 3421Search in Google Scholar

31World Health Organisation. Annex 2: Recom-mended measurement protocols and derivation of indices. In: World Health Organisation Technical Report Series 854, Physical Status: The Use and Interpretation of An-thropometry. Geneva, Switzerland: World Health Organisation, 1995: 424-438.World Health Organisation. Annex 2: Recom-mended measurement protocols and derivation of indices World Health Organisation Technical Report Series 854, Physical Status: The Use and Interpretation of An-thropometry Geneva, Switzerland World Health Organisation 1995 424438Search in Google Scholar

32Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003; 289(19): 2560-2572.ChobanianAVBakrisGLBlackHRCushmanWCGreenLAIzzoJL Jr Seventh report of the Joint National Committee on prevention detection, evaluation, and treatment of high blood pressure JAMA. 2003 289 19 2560 2572Search in Google Scholar

33Friedewald WT, Levy RI, Fredrickson DS. Estimation of the low-density lipoprotein cholesterol concentration in plasma without the use of preparative centrifuge. Clin Chem. 1972; 18(6): 499-502.FriedewaldWTLevyRIFredricksonDS. Estimation of the low-density lipoprotein cholesterol concentration in plasma without the use of preparative centrifuge Clin Chem. 1972 18 6 499 502Search in Google Scholar

34Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation. 1983; 67(4): 730-734.CastelliWPAbbottRDMcNamaraPM. Summary estimates of cholesterol used to predict coronary heart disease Circulation. 1983 67 4 730 734Search in Google Scholar

35Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted-plasma (FER_HDL). Clin Biochem. 2001; 34(7): 583-588.DobiasovaMFrohlichJ. The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted-plasma (FER_HDL) Clin Biochem. 2001 34 7 583 588Search in Google Scholar

36Nunes SOV, de Melo LGP, de Castro MRP, Barbossa S, Vargas HO, Berk M, et al. Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder. J Affect Disord. 2015; 172: 55-62. 10.1016/j.jad.2014.09.038.NunesSOVde MeloLGPde CastroMRPBarbossaSVargasHOBerkM Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder J Affect Disord. 2015 172 55 62 10.1016/j.jad.2014.09.038Open DOISearch in Google Scholar

37Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. New York, NY, USA: Routledge Academic, 1969.CohenJ. Statistical Power Analysis for the Behavioral Sciences 2nd New York NY, USA Routledge Academic 1969Search in Google Scholar

38Al-Bustan SA, Al-Serri AE, Annice BG, Alnaqeeb MA, Ebrahim GA. Re-sequencing of the APOAI promoter region and the genetic association of the -75G>A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti population. BMC Med Genet. 2013; 14: 90. 10.1186/1471-2350-14-90.Al-BustanSA Al-SerriAEAnniceBGAlnaqeebMAEbrahimGA. Re-sequencing of the APOAI promoter region and the genetic association of the -75G>A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti population BMC Med Genet. 2013 14 90 10.1186/1471-2350-14-90Open DOISearch in Google Scholar

39Saha N, Tay JS, Low PS, Humphries SE. Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genet Epidemiol. 1994; 11(3): 255-264.SahaNTayJSLowPSHumphriesSE. Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers Genet Epidemiol 1994 11 3 255264Search in Google Scholar

40Qingwei Z, Mingpeng S, Ping S, Hua Z, Mengling Z. Interaction of alcohol and G to A substitution at the promoter region of apolipoprotein AI gene in determining plasma apolipoprotein AI levels in Yi and Han Chinese. Chinese Med J. 2000; 113(5): 471-474.QingweiZMingpengSPingSHuaZMenglingZ. Interaction of alcohol and G to A substitution at the promoter region of apolipoprotein AI gene in determining plasma apolipoprotein AI levels in Yi and Han Chinese Chinese Med J. 2000 113 5 471 474Search in Google Scholar

41Li Y, Yin R, Zhou Y, Deng Y, Yang D, Pan S, et al. Associations of the apolipoprotein A-I gene polymorphism and serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations. Int J Mol Med. 2008; 21(6): 753-764.LiYYinRZhouYDengYYangDPanS Associations of the apolipoprotein A-I gene polymorphism and serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations Int J Mol Med. 2008 21 6 753 764Search in Google Scholar

42Kessling AM, Horsthempke B, Humphries SE. A study of DNA polymorphism around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet. 1985; 28(4): 296-306.KesslingAMHorsthempkeBHumphriesSE. A study of DNA polymorphism around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals Clin Genet. 1985 28 4 296 306Search in Google Scholar

43Ma YQ, Thomas GN, Tomlinson B. Association of two apolipoprotein A-I gene MspI polymorphisms with lipid and blood pressure levels. Int J Cardiol. 2005; 102(2): 309-314.MaYQThomasGNTomlinsonB. Association of two apolipoprotein A-I gene MspI polymorphisms with lipid and blood pressure levels Int J Cardiol. 2005 102 2 309 314Search in Google Scholar